Organigram Global (OGI) Depreciation & Amortization (CF) (2018 - 2026)

Organigram Global (OGI) posted quarterly Depreciation & Amortization (CF) of $7.3 million for Q1 2026, up 116.51% year-on-year from $3.4 million in Q1 2025, and up 104.46% on a QoQ basis from $3.6 million in Q4 2025.

Organigram Global (OGI) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends

Organigram Global (OGI) has reported Depreciation & Amortization (CF) for 7 consecutive years, with $7.3 million the latest figure, recorded in Q1 2026.

  • Quarterly Depreciation & Amortization (CF) rose 116.51% year-over-year to $7.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.2 million (up 145.73% YoY) and the FY2021 annual result came in at $6.1 million, changed N/A from the prior year.
  • Depreciation & Amortization (CF) improved to $7.3 million in Q1 2026 per OGI's latest filing, from $3.6 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for OGI reached as high as $7.3 million in Q1 2026 and fell as low as $2.4 million in Q4 2024.
  • A 3-year average of $4.2 million and a median of $3.5 million in 2025 frame the typical range for Depreciation & Amortization (CF).
  • Annual changes were most pronounced in 2025 — Depreciation & Amortization (CF) surged 47.29% — and 2026, when it surged 116.51%.
  • Year by year, Depreciation & Amortization (CF) stood at $2.4 million in 2024, then jumped by 47.29% to $3.6 million in 2025, then jumped by 104.46% to $7.3 million in 2026.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $7.3 million, $3.6 million, and $3.4 million for Q1 2026, Q4 2025, and Q1 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 239.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 119.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.04 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 22.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 676.10 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 7.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 172.00 Mn
10 Organigram Global 89.89 Mn 122.96 Mn 28.97 Mn 7.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 7.30 Mn
Mar 31, 2026 7.30 Mn
Dec 31, 2025 3.57 Mn
Dec 31, 2025 3.57 Mn
Mar 31, 2025 3.37 Mn
Mar 31, 2025 3.37 Mn
Dec 31, 2024 2.42 Mn
Dec 31, 2024 2.42 Mn
May 31, 2021 16.03 Mn
May 31, 2021 16.03 Mn
Feb 28, 2021 10.48 Mn
Feb 28, 2021 10.48 Mn
Nov 30, 2020 5.27 Mn
Nov 30, 2020 5.27 Mn
May 31, 2020 3.57 Mn
May 31, 2020 3.57 Mn
Feb 29, 2020 4.32 Mn
Feb 29, 2020 4.32 Mn
May 31, 2019 1.64 Mn
May 31, 2019 1.64 Mn